Yano Research Institute Releases Report on Japanese Generic Drug Market.Tokyo, Japan, June 9, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - From November to December 2005, the company conducted a survey of 725 general practitioners general practitioner n. Abbr. GP A physician whose practice consists of providing ongoing care covering a variety of medical problems in patients of all ages, often including referral to appropriate specialists. (less than 20 beds) and 906 hospitals (more than 300 beds), and received valid responses from 554 general practitioners (GPs) and 176 hospitals (HPs). According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the report, 77.4% of the respondents In the context of marketing research, a representative sample drawn from a larger population of people from whom information is collected and used to develop or confirm marketing strategy. (73.8% GPs and 89.2% HPs) answered that they use generic drugs generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name. , while 7.9% said that they don't use. Moreover, 13.2% of the respondents answered that they have no plan to use generic products. When asked why they use generic products (multiple answers allowed), 75% cited the reduction of the burden on patients, followed by reduction in drug price (48.8%), reduction in medical expenses (34.3%) and increase in revenue (28.5%). As for criteria in selecting generic products (multiple answers allowed), in addition to the reduction of the burden on patients (65.9%), 65.1% mentioned stability, followed by bioequivalence bioequivalence /bio·equiv·a·lence/ (-e-kwiv´ah-lens) the relationship between two preparations of the same drug in the same dosage form that have a similar bioavailability. (48.2%), contribution to hospital management (42.2%), use at other institutions (41.7%) and uniformity in indications (41.1%). The top five manufacturers of generic drugs that are used by the respondents are Sawai Pharmaceutical (43.6%), Towa Pharmaceutical (30.1%), Nichi-Iko Pharmaceutical (29.5%), Merck Hoei (28.3%), and Taiyo Yakuhin (22.5%). The report, available only in Japanese, sells for 735,000 yen ($6,620). Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion